Core Scientific, Inc./tx Cash Flow Statement
CORZ / Financials|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
Core Scientific, Inc./tx generated $278M in operating cash flow and negative free cash flow of $451M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | -$288.6M | -$1.4B | -$246.5M | -$2.1B | $47.3M | -$12.2M |
| Depreciation & Amortization | $68.9M | $113.2M | $96.0M | $225.3M | $33.4M | $9.4M |
| Operating Cash Flow | $278.3M | $42.9M | $65.1M | $205.2M | -$56.7M | -$23.8M |
| Capital Expenditures | $729.0M | $95.0M | $16.2M | $384.0M | $0 | $0 |
| Free Cash Flow | -$450.8M | -$52.1M | $49.0M | -$178.8M | -$56.7M | -$23.8M |
| Share Buybacks | - | $0 | $0 | $31.6M | - | - |
| FCF Margin | -141.3% | -10.2% | 9.7% | -27.9% | -10.4% | -39.4% |